IDG/Sanzay
- Primary DI
- 00850053916045
- Brand
- IDG/Sanzay
- Company
- IDG/SANZAY Corporation
- Model
- 1
- Catalog number
- C071
- Device description
- For the quantitative determination of direct bilirubin in human serum. For in vitro diagnostic use.
- Published
- 2024-01-08
- Public version status
- New
- Distribution status
- In Commercial Distribution
- MRI safety
- Labeling does not contain MRI Safety Information
- OTC
- true
Product Codes#
| Code | Name |
|---|---|
| CIG | Diazo Colorimetry, Bilirubin |
Product Code Classifications#
| Code | Device | Specialty | Class |
|---|---|---|---|
| CIG | Diazo Colorimetry, Bilirubin | Clinical Chemistry | 2 |
Premarket Submissions#
| Submission | Supplement |
|---|---|
| K881172 | 000 |
Premarket Details#
Identifiers And Packaging#
| Identifier | Type | Agency | Package quantity | Status |
|---|---|---|---|---|
| 00850053916045 | Primary | GS1 | 0 |
Alternate GTIN / UPC / EAN Codes
| Source identifier | GTIN-14 normalized | UPC-A | EAN-13 |
|---|---|---|---|
| 00850053916045 | 00850053916045 | 850053916045 | 0850053916045 |
GMDN Terms#
| Term | Definition |
|---|---|
| Conjugated (direct) bilirubin IVD, reagent | A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the quantitative measurement of conjugated (direct) bilirubin in a clinical specimen. |
Device Sizes#
| Type | Value | Unit |
|---|---|---|
| Total Volume | 1 | Liter |
| Total Volume | 100 | Milliliter |
| Total Volume | 240 | Milliliter |
| Total Volume | 250 | Milliliter |
| Total Volume | 480 | Milliliter |
Storage And Handling#
| Type | Low | High | Condition |
|---|---|---|---|
| Storage Environment Temperature | 15 Degrees Celsius | 30 Degrees Celsius |
Regulatory Flags#
- DUNS number
- 948875013
- Device count
- 1
- Lot or batch
- true
- Expiration date on label
- true
Other Devices From This Company#
| Primary DI | Brand | Model | Catalog | Published |
|---|---|---|---|---|
| 00850053916212 | IDG/Sanzay | 1 | HCC1 | 2024-01-12 |
| 00850053916229 | IDG/Sanzay | 1 | HCC2 | 2024-01-12 |
| 00850053916007 | IDG/Sanzay | 1 | C021 | 2023-12-18 |
| 00850053916205 | IDG/Sanzay | 1 | HC301 | 2024-07-03 |
| 00850053916267 | IDG/Sanzay | 1 | QS01 | 2024-07-03 |
| 00850053916113 | IDG/Sanzay | 1 | C243 | 2024-06-25 |
| 00850053916236 | IDG/Sanzay | 1 | QC01 | 2024-06-25 |
| 00850053916243 | IDG/Sanzay | 1 | QC02 | 2024-06-25 |
| 00850053916250 | IDG/Sanzay | 1 | QS31D | 2024-06-25 |
| 00850053916137 | IDG/Sanzay | 1 | C343 | 2024-01-12 |
| 00850053916076 | IDG/Sanzay | 1 | C105 | 2024-01-15 |
| 00850053916120 | IDG/Sanzay | 1 | C321 | 2024-01-12 |
| 00850053916144 | IDG/Sanzay | 1 | C391 | 2024-01-12 |
| 00850053916151 | IDG/Sanzay | 1 | C403 | 2024-01-12 |
| 00850053916168 | IDG/Sanzay | 1 | C413 | 2024-01-12 |
| 00850053916175 | IDG/Sanzay | 1 | C501 | 2024-01-12 |
| 00850053916182 | IDG/Sanzay | 1 | HC101 | 2024-01-12 |
| 00850053916199 | IDG/Sanzay | 1 | HC201 | 2024-01-12 |
| 00850053916069 | IDG/Sanzay | 1 | C095 | 2024-01-09 |
| 00850053916083 | IDG/Sanzay | 1 | C123 | 2024-01-09 |
Other Devices Sharing Product Codes#
| Primary DI | Brand | Company | Product code | Published |
|---|---|---|---|---|
| 07613336235508 | Bilirubin Total Gen.3 | Roche Diagnostics GmbH | CIG | 2025-02-04 |
| 07613336235515 | Bilirubin Total Gen.3 | Roche Diagnostics GmbH | CIG | 2025-01-31 |
| 07613336235522 | Bilirubin Total Gen.3 | Roche Diagnostics GmbH | CIG | 2025-01-31 |
| 00630414614755 | Atellica CH Diazo Direct Bilirubin (D_DBil) | Siemens Healthcare Diagnostics Inc. | CIG | 2024-10-16 |
| 00630414614922 | Atellica CH Diazo Total Bilirubin (D_TBil) | Siemens Healthcare Diagnostics Inc. | CIG | 2024-10-16 |
| 00630414313429 | Atellica CH Diazo Direct Bilirubin (D_DBil) | Siemens Healthcare Diagnostics Inc. | CIG | 2024-10-16 |
| 00630414313436 | Atellica CH Diazo Total Bilirubin (D_TBil) | Siemens Healthcare Diagnostics Inc. | CIG | 2024-10-16 |
| 00380740167561 | ARCHITECT | ABBOTT IRELAND | CIG | 2024-08-15 |
| 00380740167578 | ARCHITECT | ABBOTT IRELAND | CIG | 2024-08-15 |
| 00380740167585 | Alinity | ABBOTT IRELAND | CIG | 2024-08-15 |
| 04015630924912 | Bilirubin Direct Gen.2 (Doumas standardization) | Roche Diagnostics GmbH | CIG | 2023-10-06 |
| 04015630927531 | Bilirubin Direct Gen.2 (Doumas standardization) | Roche Diagnostics GmbH | CIG | 2023-10-06 |
| 10673486001204 | Teco Diagnostics Direct Bilirubin TC-Matrix | TECO DIAGNOSTICS | CIG | 2023-07-21 |
| 10673486001211 | Teco Diagnostics Direct Bilirubin Reagent Set | TECO DIAGNOSTICS | CIG | 2023-07-21 |
| 10673486001280 | Teco Diagnostics Total Bilirubin TC Matrix | TECO DIAGNOSTICS | CIG | 2023-07-21 |
| 10673486001297 | Teco Diagnostics Total Bilirubin Reagent Set | TECO DIAGNOSTICS | CIG | 2023-07-21 |
| 10673486001303 | Teco Diagnostics Direct and Total Bilirubin Reagent Set | TECO DIAGNOSTICS | CIG | 2023-07-21 |
| 00852169008317 | ClearChem Diagnostics Inc. Total Bilirubin | CLEARCHEM DIAGNOSTICS INC. | CIG | 2023-01-20 |
| 00852169008324 | ClearChem Diagnostics Inc. Direct Bilirubin | CLEARCHEM DIAGNOSTICS INC. | CIG | 2023-01-20 |
| 00811727015952 | Pointe Total Bilirubin Reagent | HORIBA INSTRUMENTS INCORPORATED | CIG | 2021-01-30 |
| 00811727016133 | Pointe Direct Bilirubin Reagent | HORIBA INSTRUMENTS INCORPORATED | CIG | 2021-01-30 |
| 00811727016256 | Pointe Total Bilirubin Reagent | HORIBA INSTRUMENTS INCORPORATED | CIG | 2021-01-30 |
| 00842768014192 | Dimension® Flex® reagent cartridge URCA | Siemens Healthcare Diagnostics Inc. | CIG | 2020-09-24 |
| 03610230006870 | Yumizen C1200 Direct Bilirubin | HORIBA ABX SAS | CIG | 2020-08-28 |
| 03610230006887 | Yumizen C1200 Total Bilirubin | HORIBA ABX SAS | CIG | 2020-08-28 |
| 00811727015822 | Pointe Direct Bilirubin for BS480 | HORIBA INSTRUMENTS INCORPORATED | CIG | 2020-05-28 |
| 00380740174965 | ARCHITECT | Abbott GmbH | CIG | 2020-04-12 |
| 00380740174972 | ARCHITECT | Abbott GmbH | CIG | 2020-04-12 |
| 07613336164884 | Direct Bilirubin | Roche Diagnostics GmbH | CIG | 2020-03-13 |
| 07613336121061 | Bilirubin Direct Gen.2 | Roche Diagnostics GmbH | CIG | 2020-03-05 |